Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2008
09/02/2008CA2292910C Hair growth compositions and uses
09/02/2008CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators
08/2008
08/28/2008WO2008103949A1 Modulators of pharmacokinetic properties of therapeutics
08/28/2008WO2008103615A1 Isoquinolines useful as inducible nitric oxide synthase inhibitors
08/28/2008WO2008103613A2 Hydroxylamine compounds and methods of their use
08/28/2008WO2008103500A1 Thiazole derivatives as modulators of g protein-coupled receptors
08/28/2008WO2008103351A2 Heterocyclic aspartyl protease inhibitors
08/28/2008WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008WO2008101995A1 Indole derivatives
08/28/2008WO2008101905A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008WO2008081399A3 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008WO2008051637A3 Pyridazinone compounds
08/28/2008WO2008005764A3 Novel zeta-cypermethrin composition
08/28/2008WO2007087488A9 Indole sulfonamide modulators of progesterone receptors
08/28/2008WO2007073497A3 Calcium channel antagonists
08/28/2008WO2007072142A3 Benzimidazole-5-carboxamide derivatives
08/28/2008US20080207912 Reacting2-( 2-aminothiazol-4-yl)-2-methyloxyimino acetic acid-2-benzothiazolyl thioester with 7-amino-3-(2-furocarbonylthiomethyl)-3-cephem-4-carboxylic acid
08/28/2008US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases
08/28/2008US20080207705 Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
08/28/2008US20080207704 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
08/28/2008US20080207700 Amino Acid Salts of Rosiglitazone
08/28/2008US20080207698 Novel Compounds 569
08/28/2008US20080207685 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
08/28/2008US20080207641 Immunosuppressants; antiallergens
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207620 Modulators of pharmacokinetic properties of therapeutics
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207607 Antiarthritic agents; antiinflammatory agents; arteriosclerosis; multiple sclerosis
08/28/2008US20080207598 Indole derivatives
08/28/2008CA2679066A1 Hydroxylamine compounds and methods of their use
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2678907A1 Modulators of pharmacokinetic properties of therapeutics
08/28/2008CA2678147A1 Indole derivatives
08/28/2008CA2677949A1 Iminipyridine derivatives and their uses as microbiocides
08/28/2008CA2677705A1 Thiazole derivatives as modulators of g protein-coupled receptors
08/28/2008CA2677565A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1960392A2 Heterocycle-substituted 3-alkyl azetidine derivatives
08/27/2008EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor
08/27/2008EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
08/27/2008EP1960385A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase
08/27/2008EP1960377A1 l , l , 3-TRI0X0-l , 2 , 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS
08/27/2008EP1960370A1 Pyridiazinone derivatives for tumour treatment
08/27/2008EP1960367A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
08/27/2008EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
08/27/2008EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
08/27/2008EP1694659B1 Thiadiazoles as cxc- and cc- chemokine receptor ligands
08/27/2008EP1644368B1 Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
08/27/2008EP1620431B1 3-carbonylaminothiophenes and their use as fungicides
08/27/2008EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
08/27/2008CN101253172A N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
08/27/2008CN101253171A Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
08/27/2008CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists
08/27/2008CN101250186A Thiadiazoles sym-triazine derivative and preparation method thereof
08/27/2008CN101250165A Insecticidal bis-heterocyclic compounds
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413862C Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/27/2008CN100413849C Benzimidazole derivatives
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417150 Azoles having an insecticidal action
08/26/2008US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent
08/26/2008US7417062 e.g. N (S)-(1-Cyclohexylmethyl-pyrrolidine-2-ylmethyl)-3,4-dimethoxy-N-naphthalen-2-ylmethyl-benzamide; inhibit the binding of the SDF-1 (CXCL12) chemokine or I-TAC (CXCL11) to the chemokine receptor CCXCKR2; anticarcinogenic agent; breast, lymph nodes, bone marrow, and lungs cancer
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent
08/21/2008WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008WO2008100459A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008099944A1 Crystalline forms of thiazolidinedione derivative and its manufacturing method
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases
08/21/2008WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof
08/21/2008WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof
08/21/2008WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008098949A2 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
08/21/2008WO2008080134A3 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
08/21/2008WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
08/21/2008WO2007139955A3 Triazole compounds that modulate hsp90 activity
08/21/2008WO2007045962A3 Novel hdac inhibitors
08/21/2008US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents
08/21/2008US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives
08/21/2008US20080200470 serotonin 5-HT1A receptor agonists; N-heterocyclclediones substituted with a chroman-2-yl, 2-quinolyl, or phenoxy group; 2-[4-[(Chroman-2-yl)methylamino]butyl]-1,3-dioxoperhydroimidazo[1,5-a]pyridine; Parkinson's, cerebral damage by thromboembolitic ictus, depression, migraine, psychosis, urinary disorde
08/21/2008US20080200469 Phthalazinone derivatives
08/21/2008US20080200465 Antipathogenic benzamide compounds
08/21/2008US20080200463 N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer
08/21/2008US20080200460 Chemical Compounds
08/21/2008US20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands
08/21/2008CA2728541A1 Crystalline forms of thiazolidinedione compound and its manufacturing method
08/21/2008CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678069A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008CA2677586A1 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
08/21/2008CA2676715A1 Piperazine derivatives for treatment of ad and related conditions
08/21/2008CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
08/21/2008CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors